During the past decade, UCLA Center for Behavioral and Addiction Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Center for Behavioral and Addiction Medicine" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator and "University of California, Los Angeles" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Center for Behavioral and Addiction Medicine" are "Opioid-use Disorder" (2 trials). Many other conditions were trialed in "UCLA Center for Behavioral and Addiction Medicine" in a lesser frequency.

Most popular intervention types in "UCLA Center for Behavioral and Addiction Medicine" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Opioid Addiction Recovery Support Software Platform" (2 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Center for Behavioral and Addiction Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Center for Behavioral and Addiction Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in UCLA Center for Behavioral and Addiction Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Center for Behavioral and Addiction Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".